Quantum Biopharma (QNTM) Profit After Tax (2019 - 2026)

Quantum Biopharma's Profit After Tax history runs 8 years deep, the most recent figure standing at -$3.0 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 65.8% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$15.3 million (down 340.62% YoY), while the FY2025 annual figure was -$27.0 million, down 80.73% from the prior year.
• Profit After Tax came in at -$3.0 million for Q1 2026 at Quantum Biopharma, down from -$2.5 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $8.0 million in Q2 2022 to a low of -$47.3 million in Q4 2022.
• A 5-year average of -$5.0 million and a median of -$2.1 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax jumped 254.96% in 2024 and tumbled 317.89% in 2025, its largest moves.
• Quantum Biopharma's Profit After Tax stood at -$47.3 million in 2022, then grew by 26.34% to -$34.8 million in 2023, then surged by 93.99% to -$2.1 million in 2024, then declined by 21.04% to -$2.5 million in 2025, then slipped by 18.08% to -$3.0 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$3.0 million, -$2.5 million, and -$4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison